Pharmacokinetics and Pharmacodynamics of Etravirine 400 mg Once Daily in Treatment-Naïve Patients

MLA

Glynn A. Morrish, et al. “Pharmacokinetics and Pharmacodynamics of Etravirine 400 Mg Once Daily in Treatment-Naïve Patients.” HIV Clinical Trials, vol. 14, June 2013, pp. 92–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b9978147638dafa52ed1bc92efb1ea51&authtype=sso&custid=ns315887.

APA

Glynn A. Morrish, Gerd Faetkenheuer, Bruce Green, Markus Bickel, Michael Kurowski, Yvon van Delft, Thomas N. Kakuda, Andrew Hill, & Giovanni Di Perri. (2013). Pharmacokinetics and Pharmacodynamics of Etravirine 400 mg Once Daily in Treatment-Naïve Patients. HIV Clinical Trials, 14, 92–98.

Chicago

Glynn A. Morrish, Gerd Faetkenheuer, Bruce Green, Markus Bickel, Michael Kurowski, Yvon van Delft, Thomas N. Kakuda, Andrew Hill, and Giovanni Di Perri. 2013. “Pharmacokinetics and Pharmacodynamics of Etravirine 400 Mg Once Daily in Treatment-Naïve Patients.” HIV Clinical Trials 14 (June): 92–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b9978147638dafa52ed1bc92efb1ea51&authtype=sso&custid=ns315887.